Paroxysmal Supraventricular Tachycardia In A Child: A Clinical Case Treated With Amiodarone And Management
Main Article Content
Abstract
This report presents a case of a Vietnamese child with paroxysmal supraventricular tachycardia and discusses diagnosis and management, clinical features, and electrocardiogram to help diagnose arrhythmia in children. This girl child, Acute management has been more successful when using Amiodarone in the absence of some first-line drugs such as Adenosine as well as some other conventional drugs that require caution. However, long-term management continues to be a topic of debate, especially in special situations.
Article Details
References
Kertesz NJ, Friedman RA, Fenrich AL, Garson A., Jr. Current management of infants and children with Supraventricular Tachycardia. Cardiol Rev. 1998; 6: 221–230.
Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, et al. ACC/AHA/ESC guiderlines for the management of patients with supraventricular arrhythmias-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European society of Cardiology Committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol 2003; 42: 1493-1531.
Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2016; 67: 1575-1623.
Katritsis DG, Boriani G, Cosio FG, Hindricks G, Jais P, Josephson ME, et al. European Heart Rhythm Association (EHRA) consensus document on the management of Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulation Cardiaca y Electrofisiologia (SOLAECE). Eur Heart J 2018; 39: 1442-1445.
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Europe 2018; 20: 157-208.
Mairess GH, Moran P, Van Gelder IC, Elsner C, Rosenqvist M, Mant J, et al. ESC Scientific Document Group. Screening for atrial fibrillation: a EHRA, HRS, APHRS, SOLAECE. Europace 2017; 19: 1589-1623.
Lip GYH, Collet JP, Haude M, Huber K. Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI: a summary of the Joint Consensus Document of the EHRA, EAPCI, ACCA, HRS, APHRS, LAHRS, CASSA. Eur Heart J 2018; 39: 2847-2850.
Fish F, Benson W. Disorders of cardiac rhythm and conduction. In: Emmanouilides GC, Allen HD, Riemenschneider TA, Gutgesell HP, editors. Moss and Adams Heart Disease in Infants, Children, and Adolescents Including the Fetus and Young Adult. Baltimore: Williams & Wilkins; 199: 1555–603.
Ko JK, Deal BJ, Strasburger JF, Benson DW. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992; 69: 1028–32.
Dunnigan A, Bendirt DG, Benson DW., Jr Modes of onset (“initiating events”) for paroxysmal atrial tachycardia in infants and children. Am J Cardiol. 1986; 57: 1280–7.
Garson A, Jr, Gillette PC, McNamara DG. Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr. 1981; 98: 875–82.
Orejarena LA, Vidaillet H, DeStefano F, Nordstrom DL, et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 1998; 31: 150-157
Wu MH, Chen HC, Kao FY, Hoang SK. Postnatal cumulative incidence of supraventricular tachycardia in a general pediatric population: a national birth cohort database study. Heart Rhythm 2016; 13: 2070-2075.
SD Chu, SG Tran, MT Tran, KQ Pham. European Journal of Molecular & Clinical Medicine 2020; 7 (1): 2020.
Garson A, Jr, Gillette PC, McNamara DG. Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr. 1981; 98: 875–82.
Link. MS: Evaluation and Initial treatment of superventricular tachycardia. N Eng J Med 2012; 367: 1438-1448.
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893-2962.
Wit AL, Wellns HJ, Josephson ME. Electrophysiological foundations of cardiac arrhythmias. 1st ed. Minneapolis: Cardiotext Publishing; 2017.
Klein I, Ojamaa K, Thyroid hormones and the cardiovascular system. N Engl J Med 2001; 344: 501-509.
Ortiz M, Martin A, Arribas F, Coll-Vinent B, Del Arco C, Peinado R, Almendral J. PROCAMIO Study Investigators. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. Eur Heart J 2017; 38: 1329-1335.
Salem JE, Dureau P, Funck-Brentano C, Hulot JS, El-Aisaoui M, Urien S, et al. Effectiveness of heart rate control on hemodynamics in critically ill patients with atrial tachyarrhythmias managed by amiodarone. Pharmacol Res 2001; 87: 886-890.
Muller G, Deal BJ, Benson DW., Jr “Vagal maneuvers” and adenosine for termination of atrioventricular reentrant tachycardia. Am J Cardiol. 1994; 74: 500–3.
Ralston MA, Knilans TK, Hannon DW, Daniels SR. Use of adenosine for diagnosis and treatment of tachyarrhythmias in pediatric patients. J Pediatr. 1994; 124:139–43.
Till J, Shinebourne EA, Rigby ML, Clarke B, Ward DE, Rowland E. Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children. Br Heart J. 1989; 62: 204–11.
Rankin AC, Rae AP, Houston A. Acceleration of ventricular response to atrial fibrillation after intravenous adenosine. Br Heart J. 1993; 69: 263–5.
Epstein ML, Kiel EA, Victoria BE. Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia. Pediatrics. 1985; 75: 737–40.
Perry JC, Garson A., Jr Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence. J Am Coll Cardiol. 1990; 16: 1215–20.
Franklin WH, Deal BJ, Strasburger JF. Do infants have medically refractory supraventricular tachycardia [abstract]? J Am Coll Cardiol. 1994; 23: 250A.
Weindling SN, Saul JP, Walsh EP. Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J. 1996; 131: 66–72.
Atkins DL, Kerber RE. Pediatric defibrillation: current flow is improved by using “adult” electrode paddles. Pediatrics. 1994; 94: 90–3.
Kugler JD, Danford DA, Deal BJ, Gillette PC, Perry JC, Silka MJ, Van Hare GF, Walsh EP, for the Pediatric Electrophysiology Society Radiofrequency catheter ablation in children and adolescents. N Engl J Med. 1994; 330: 1481–7.
Kugler JD, Danford DA, Felix G, Houston K, other members of Pediatric Electrophysiology Society RFCA Registry Follow-up of pediatric radiofrequency catheter ablation registry patients. Circulation. 1995; 92: 765A.
Kugler JD, Houston K, other participating members of Pediatric EP Society Pediatric Radiofrequency Catheter Ablation (RFCA) Registry: update of immediate results. PACE. 1995; 18: 814A.
Lundberg A. Paroxysmal atrial tachycardia in infancy: long-term follow-up study of 49 subjects. Pediatrics. 1982; 70: 638–42.